These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24613022)

  • 21. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
    Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S
    Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
    Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
    Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of suitable reference microRNA for qPCR analysis in pediatric inflammatory bowel disease.
    Buonpane C; Ares G; Benyamen B; Yuan C; Hunter CJ
    Physiol Genomics; 2019 May; 51(5):169-175. PubMed ID: 30978148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
    Atanassova A; Georgieva A
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa-miR-375 promotes the progression of inflammatory bowel disease by upregulating TLR4.
    Wu CP; Bi YJ; Liu DM; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7543-7549. PubMed ID: 31539144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic changes in defunctioned rectums in patients with inflammatory bowel disease: a clinicopathologic study of 82 patients with long-term follow-up.
    Asplund S; Gramlich T; Fazio V; Petras R
    Dis Colon Rectum; 2002 Sep; 45(9):1206-13. PubMed ID: 12352238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.
    Yamamoto H; Morise K; Kusugami K; Furusawa A; Konagaya T; Nishio Y; Kaneko H; Uchida K; Nagai H; Mitsuma T; Nagura H
    J Gastroenterol; 1996 Aug; 31(4):525-32. PubMed ID: 8844473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
    Ye YL; Pang Z; Gu W; Zheng JJ
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
    [No Abstract]   [Full Text] [Related]  

  • 29. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and colonoscopic characteristics of pediatric inflammatory bowel disease].
    Luo YY; Chen J
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):129-33. PubMed ID: 19573460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
    Tian Y; Xu J; Li Y; Zhao R; Du S; Lv C; Wu W; Liu R; Sheng X; Song Y; Bi X; Li G; Li M; Wu X; Lou P; You H; Cui W; Sun J; Shuai J; Ren F; Zhang B; Guo M; Hou X; Wu K; Xue L; Zhang H; Plikus MV; Cong Y; Lengner CJ; Liu Z; Yu Z
    Gastroenterology; 2019 Jun; 156(8):2281-2296.e6. PubMed ID: 30779922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.
    Wang H; Chao K; Ng SC; Bai AH; Yu Q; Yu J; Li M; Cui Y; Chen M; Hu JF; Zhang S
    Genome Biol; 2016 Mar; 17():58. PubMed ID: 27029486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal mucosal nitric oxide in differentiation of inflammatory bowel disease and irritable bowel syndrome.
    Reinders CI; Herulf M; Ljung T; Hollenberg J; Weitzberg E; Lundberg JO; Hellström PM
    Clin Gastroenterol Hepatol; 2005 Aug; 3(8):777-83. PubMed ID: 16234006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
    Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
    Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G
    Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
    Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
    PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
    PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.